SCHEMBL3630458

SCHEMBL3630458

CNc1nc(NC2CCC(NC(=O)O)CC2)c(F)cc1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FER P16591 2/20 0.40
PDE4B Q07343 4/20 0.39
PDE4D Q08499 4/20 0.39
PDE4A P27815 3/20 0.39
PDE4C Q08493 3/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
IRAK4 Q9NWZ3 3/20 0.38
ACHE P22303 1/20 0.38
KCNH2 Q12809 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LRRK2 Q5S007 1/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3630454 1.00 KDM4E (0.41) KDM4ESMN1; SMN2FERPDE4BPDE4D
SCHEMBL3624947 0.85 ACHE (0.46) PDE4BPDE4DPDE4APDE4CROCK2
SCHEMBL3624945 0.85 ACHE (0.46) PDE4BPDE4DPDE4APDE4CROCK2
SCHEMBL3628370 0.84 ROCK2 (0.53) KDM4ESMN1; SMN2FERPDE4BPDE4D
SCHEMBL3628372 0.84 ROCK2 (0.53) KDM4ESMN1; SMN2FERPDE4BPDE4D
SCHEMBL3628132 0.84 ROCK2 (0.43) KDM4EFERPDE4BPDE4DPDE4A
SCHEMBL3628130 0.84 ROCK2 (0.43) KDM4EFERPDE4BPDE4DPDE4A
SCHEMBL1936927 0.82 ROCK2 (0.35) KDM4ESMN1; SMN2FERROCK2ROCK1
SCHEMBL1936926 0.82 ROCK2 (0.35) KDM4ESMN1; SMN2FERROCK2ROCK1
SCHEMBL3627799 0.81 LMNA (0.49) PDE4BPDE4DPDE4APDE4CROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032875-A2 HETEROCYCLIC CARBOXAMIDE COMPOUNDS ASTELLAS PHARMA INC. (JP) 2010-03-25 WO disclosed